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Clinical summaries
PATIENT 1. A 33-year-old man was referred in September
1994 for the treatment of a mitral valve tumor, which was
diagnosed after the occurrence of a stroke. In July 1994 the
patient had had 2 successive cerebrovascular accidents. The
arising sequelae were oculomotor paralysis and aphasia. The
patient’s previous medical history was otherwise uneventful.
At cardiac examination the patient was in sinus rhythm. The
carotid and peripheral pulses were normal. Results of biologic,
electrocardiographic, chest radiographic, and carotid duplex
ultrasonographic studies were all within normal limits. A
cerebral computed tomographic scan showed an infarct with-
in the distribution of the left superficial sylvian artery.
Angiography revealed occlusion of the distal branches of the
sylvian artery, suggesting an embolic cause. Transthoracic
echocardiography (TTE) revealed a mobile mass on the mitral
valve. Further evaluation with transesophageal echocardiogra-
phy (TEE) revealed a tumor attached to the anterior leaflet
and measuring approximately 1 cm.
An operation was performed on September 2, 1994.
Surgical findings consisted of a solitary verrucous tumor aris-
ing from the atrial side of the anterior mitral leaflet (Fig 1).
The tumor was excised, and the valve was repaired with sim-
ple interrupted suture of the valvular edges. Histopathologic
examination confirmed the diagnosis of a CPFE with an
attached thrombus. The patient had an uneventful postopera-
tive recovery. At 3 years of follow-up there was good neuro-
logic recovery and TTE showed no valvular abnormalities.
C ardiac papillary fibroelastomas (CPFEs) are rarebenign tumors that can have important clinical
implications. CPFEs are characteristically small and
solitary, with multiple papillary fronds resembling a sea
anemone, and they are most often found on the valvular
endocardium.1,2 Before the availability of echocardiog-
raphy, CPFEs were usually found incidental to autopsy
or cardiac operations.1-3 The first surgical excision was
reported by Lichtenstein and associates4 in 1976. A lit-
erature review found 198 cases of CPFE. Most were
described as incidental autopsy findings. Surgical exci-
sion was performed in 71 cases. The 4 cases described
in this report demonstrate the complications of CPFE
and the operative findings. Although these lesions are
benign, early recognition and treatment are fundamen-
tal because they can cause fatal complications.
Objective: We have reviewed the case histories of 4 patients who under-
went operations between September 1994 and November 1997 at
Broussais Hospital for cardiac valvular papillary fibroelastoma.
Methods: Diagnosis was strongly suggested by echocardiography. Tumor
locations were mitral (1), tricuspid (1), and aortic (2). Indications for
operation were previous stroke for the mitral tumor, prophylaxis for the
tricuspid tumor, syncopal episodes for the first aortic tumor, and tran-
sient ischemic attack and mesenteric ischemia for the second aortic
tumor. Results: Surgical excision with a conservative, valve-sparing
approach was performed in all cases. For the first aortic tumor, aortic
valve reconstruction was achieved with part of a cryopreserved aortic
homograft cusp. Intraoperative transesophageal echocardiography
showed no evidence of valvular regurgitation after excision in all cases.
All patients had uneventful postoperative recoveries. No evidence of
regurgitation or recurrence was seen on echocardiography at follow-up.
Conclusions: Despite their histologically benign aspect, cardiac papillary
fibroelastomas should be excised because of potential embolic complica-
tions. A conservative, valve-sparing approach is recommended, howev-
er, because of the absence of recurrence after total excision. (J Thorac
Cardiovasc Surg 1999;117:106-10)
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PATIENT 2. A 65-year-old man was referred in November
1994 for coronary artery bypass grafting. His previous med-
ical history was significant for an anterior myocardial infarc-
tion in October 1994. The patient underwent coronary artery
bypass grafting (4 grafts) and was discharged from the hospi-
tal on postoperative day 9. During his convalescence, TTE
revealed a mass on the tricuspid valve. TEE demonstrated a
solitary tumor attached to the atrial aspect of the tricuspid
valve and measuring approximately 2 cm, without abnormal-
ities of the other valves (Fig 2). Results of pulmonary scintig-
raphy were within normal limits.
The patient was reoperated on in July 1995. Surgical find-
ings consisted of a CPFE (confirmed by histopathologic
examination) attached to the atrial side of the septal tricuspid
leaflet. The tumor was excised, and the tricuspid valve repair
was achieved with simple sutures at the edge of the resection.
The patient’s postoperative course was uneventful. TTE at 3
years of follow-up showed no valvular abnormalities.
PATIENT 3. A 62-year-old man was referred in September
1995 for a tumor of the aortic valve. The patient had an
uneventful previous medical history except for a hiatal hernia.
He had been previously admitted to his referring hospital
because of an unexplained loss of consciousness while walk-
ing on August 28, 1995. At admission, results of clinical
examination, electrocardiography, and chest radiography
were all unremarkable, but TTE and TEE detected a mobile
echodense mass (15 · 15 mm) arising from the aortic valve.
Differentiation of this mass as a tumor, a thrombus, or vege-
tation was not possible before the operation; however, there
was no evidence of endocarditis and multiple blood cultures
yielded negative results. This solitary tumor was attached to
the right aortic cusp by a short pedicle. The tumor was mobile
on the aortic surface of the cusp, with a tendency toward pro-
lapse into the right coronary ostium, suggesting the possibil-
ity of an intermittent right coronary ostial obstruction. No
other evidence of valve pathology was found.
The operation was performed on September 20, 1995.
Surgical findings consisted of a CPFE (confirmed by histo-
pathologic examination) attached near the free edge of the
right aortic cusp and mobile within the right coronary sinus of
Valsalva. The tumor and a third of the right aortic cusp were
removed. Restoration of normal right cusp architecture was
achieved with part of a cryopreserved aortic homograft cusp.
Intraoperative TEE showed no evidence of valvular regurgi-
tation. The patient’s postoperative course was uneventful.
TTE at 3 years of follow-up showed no valvular abnormali-
ties.
PATIENT 4. A 55-year-old woman was referred in November
1997 for an aortic valve tumor. The patient’s previous med-
ical history was notable for a transient ischemic attack in
April 1997. Results of medical examination, coagulation
tests, electrocardiography, cerebral computed tomographic
scan, and TTE were normal. In June 1997 the patient had an
acute mesenteric infarction, necessitating a small-bowel
resection followed by anticoagulant treatment. Histologic
analysis of the resected bowel did not contribute to a precise
diagnosis but did suggest an embolic cause. Results of med-
ical examination, laboratory test, electrocardiography, chest
radiography, and abdominal echocardiography were normal.
TTE did not reveal any valvular abnormalities; however, TEE
showed a mobile mass (<1 cm) attached to the noncoronary
cusp of the aortic valve (Fig 3).
The patient underwent surgical resection in November
1997. The intraoperative finding consisted of a CPFE (con-
firmed by histologic examination) attached to the free edge of
the aortic valve cusp facing the noncoronary sinus. Simple
excision of the tumor was performed. Intraoperative TTE
showed no aortic valve regurgitation. The patient’s postoper-
ative course was uneventful.
Discussion
CPFEs are classified as primary benign endocardial
tumors.1,2 Nomenclature can be confusing, because
many names have been used to describe this tumor.1-3
Papillary fibroelastoma is the most widely accepted
term. Primary cardiac neoplasms are rare, with an inci-
Fig 1. Operative view of the mitral CPFE arising from the
atrial side of the anterior mitral leaflet.
Fig 2. Preoperative TEE view of the CPFE adherent to the
atrial side of the tricuspid leaflet.
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dence at autopsy ranging between 0.002% and 0.33%.1,5
Eighty percent of these primary cardiac neoplasms are
benign tumors, with CPFE as the third most common
type, after myxoma and lipoma but before heman-
gioma.1,5 In 1971 Abu Nassar and Parker2 reported on 39
cases in a literature review of CPFE, and McAllister and
Fenoglio1 collected 42 cases from the Armed Forces
Institute of Pathology database in 1977. To date 198
cases of CPFE have been reported in the literature.
CPFEs are small, avascular, benign tumors. They are
derived from the normal components of endocardium
(fibrous tissue, elastic fibers, and smooth muscle cells).
Characteristically they have multiple papillary fronds,
resembling a sea anemone, and usually are attached to
the endocardium by a short pedicle.1,3 Histologically
the papillary fronds consist of a central core of dense
connective tissue surrounded by a layer of loose con-
nective tissue and covered by hyperplastic endothelial
cells (Fig 4).1-4
CPFEs can arise from virtually any endocardial sur-
face, but they most often originate from the valvular
endocardium.1,3,4 Eighty-four percent of the tumors in
the 198 collected cases of CPFE (n = 171) arose from
cardiac valves. CPFE is by far the most common tumor
arising from cardiac valves. Eighty-eight percent of the
132 valvular tumors and 71% of the 56 valvular tumors
studied by Ryan and associates6 and by Edwards and
associates,7 respectively, were CPFEs. CPFE affect
each of the 4 cardiac valves with nearly equal frequen-
cies.1,3 Precise data concerning locations of the tumor
were available for 173 patients in the literature (Fig 5).
Among these, the aortic valve was the site of involve-
ment in 51 cases (29%), the mitral valve was the site in
43 cases (25%), the tricuspid valve was the site in 29
cases (17%), and the pulmonary valve was the site in
23 cases (13%, Fig 1). CPFEs arising from semilunar
valves are located with nearly equal frequencies on the
ventricular and arterial sides of the valve and may be
situated anywhere on the valve.1-3 In the case of the
atrioventricular valves, the tumor usually arises on the
middle portion of the valve and generally projects into
the atrium.1-3 Nonvalvular locations, observed in
15.7% of the 198 collected cases, include left and right
ventricular mural and septal endocardial walls,1-5,8-10
right and left atrial endocardium,1,2,11 papillary mus-
cle,2,12 chordae tendinae,2,12 and intima of the right
coronary ostium.13 In anatomic series, CPFEs occur
with equal frequency on the left and right sides of the
heart,1,3,5,7 but 81% of the CPFEs reportedly surgically
excised were located on the left side. In fact, CPFEs are
usually solitary tumors, and multiple CPFEs have been
found in only few instances (7.5% of the collected
cases).1,2,6,7,12,14,15
Generally a CPFE is a small lesion, ranging in size
from 0.1 to 5.7 cm and mostly measuring less than 1.5
cm.3 Most cases of CPFE have been encountered in
Fig 3. Preoperative TEE view of the CPFE adherent to the
noncoronary cusp of the aortic valve.
Fig 4. Histologic section of a resected CPFE. The papillary
fronds are lined by endothelial cells. The matrix consists of
mucopolysaccharide, elastic fibers, and rare spindle cells.
(Hematoxylin and eosin stain; original magnification · 25.)
Fig 5. Locations of 173 CPFEs.
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adults, usually in patients in the sixth decade or beyond
(ranging from a 6-day-old neonate to a 92-year-old
woman).3 They occur equally in male and female
patients.3 Initially described as an incidental finding at
autopsy (63% of the collected cases) or surgery, the
clinical significance of CPFEs has been debated at
length.2 The evidence that CPFEs can cause cardiac or
neurologic symptoms is now well established. Among
the 71 patients whose operations for CPFE removal are
reported on in the literature, neurologic accidents were
the most common symptoms (48%, Table I). CPFEs
have a significant propensity toward embolization,
causing transient ischemic attack, stroke, angina, myo-
cardial infarction, pulmonary embolism, congestive
heart failure, near syncope, and sudden death.3,16-30
Embolization may occur from fragments of the papil-
lary fronds of the tumor itself or from a thrombus that
frequently forms around the tumor. In fact, the tumor
can be a nidus for platelet and fibrin aggregates that
subsequently embolize.3,16 Because results of physical
examination are generally normal in patients with
CPFEs, 2-dimensional echocardiography is necessary
in young patients with transient ischemic attacks or
strokes, even in the absence of clinical or electrocar-
diographic evidence of heart disease. Furthermore, it is
of interest that CPFE may also cause obstructive car-
diac symptoms,3,11,13 being responsible of left or right
ventricular outflow tract obstruction and dynamic ostial
coronary obstruction, as described for patient 3 in our
series.
During diagnostic workup of patients with suspected
CPFE, these tumors have been detected as filling defects
on cardioangiographic studies.3 Even in an 83-year-old
woman who could not be operated on, a diagnosis was
established by percutaneous transfemoral biopsy of a
right atrial tumor seen on angiography.11 At present con-
ventional TTE and TEE with multiplanar studies are the
best means in establishing the diagnosis.3,12,14,21,31-33 The
high resolution of TEE can locate the central collage-
nous core of the tumor and distinguish it from the rest of
the mass by its bright echocardiographic appearance.25,26
If clearly identified, this central echodense contrast
should allow differentiation of CPFEs from other intrac-
ardiac tumors, especially myxomas, but also from vege-
tations or mural thrombi.3,15
The potential for life-threatening complications of
CPFE is an indication for their surgical excision. It is
recognized that even small CPFEs (3 mm) can be
responsible for strokes,3 and we therefore consider that
these tumors, even in patients without symptoms,
should be surgically managed as long as there are no
major contraindications to the operation. At diagnosis,
prophylactic anticoagulation should be initiated.
Intraoperative TEE can be a useful adjunct in eliminat-
ing multiple tumor locations and in assessing the ade-
quacy of valve repair.15,26 Intracardiac videothoraco-
scopic techniques have been reported in the treatment
of left ventricular tumors.10 A conservative surgical
approach is recommended and is generally possible
(86% of the 71 surgical procedures of the collected
cases), with standard valvular repair techniques used
after tumor resection. Nevertheless, we used part of a
cryopreserved aortic homograft cusp to achieve
restoration of normal right cusp architecture in our
third patient. This excellent tissue provided a better
repair than an autologous pericardial patch would have
done. Recurrence after surgical excision is as yet
unknown, and the first 3 patients reported on here have
no evidence of recurrence at 3 years of follow-up.
Despite their benign pathologic aspect, CPFEs
should be surgically managed, even in patients without
symptoms. A conservative, valve-sparing approach is
generally possible, and the use of homograft tissues can
be of benefit. Recurrence after surgical excision is at
yet unknown; however, careful follow-up is warranted.
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